Biotechnology News MERIDIA Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-6 out of 6 found

Current Search: meridia: 6

Sanofi obesity drug gets final okay from UK's NICE
-0400 (Reuters Health) LONDON (Reuters) - Sanofi-Aventis won a final green light for its obesity drug Acomplia from Britain's cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health...

Reuters Health: Jun 26 2008 1:23AM
Matching: meridia

Find similar documents

Controversial obesity drug gets final okay
Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.

Font Scale:A A A Sanofi-Aventis won a final...

Christian Today: Jun 25 2008 11:35AM
Matching: meridia

Find similar documents

Controversial obesity drug gets final okay
Reuters - 2 hours 7 minutes ago LONDON (Reuters) - Sanofi-Aventis won a final green light for its obesity drug Acomplia from cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health...

Yahoo! UK and Ireland: Jun 25 2008 6:28AM
Matching: meridia

Find similar documents

Pharmaceutical solutions to obesity iffy at best, experts say
For an activity that seems to come so naturally to so many Americans, getting fat is actually quite complicated.

Not surprisingly, then, so is developing a pill that will help reverse that process.Day after day, the appetite must be...

Longview Daily News: Jun 18 2008 9:18AM
Matching: meridia

Find similar documents

Diverting a diet drug
the first weight-loss drug to be available without a prescription?

Illustrations by Bill Sanderson Related Articles According to the US Food and Drug Administration, Americans spend $18 billion per year on nonprescription dietary...

The Scientist: Jun 10 2008 5:11PM
Matching: meridia

Find similar documents

Research and Markets: Thought leaders share their perspectives on the pipeline of obesity drugs in new study
(M2 PressWIRE Via Acquire Media NewsEdge) RDATE:02062008 Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c93394) has announced the addition of Thought Leader Insight & Analysis: Obesity to their offering.

TMC Net: Jun 2 2008 2:09PM
Matching: meridia

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.